G. Müller‐Berghaus

Author

G. Müller‐Berghaus

Also Known As

G MULLERBERGHAUS, G Muller-Berghaus, G Mûller-Berghaus, G Müller-Berghaus, G. MULLER-BERGHAUS, G. MÜLLER‐BERGHAUS, G. Müller-Berghaus, G. Müller‐Berghaus, Gert Muller-Berghaus, Gert MÜLLER‐BERGHAUS

177

Publications

6.5K

Citations

H-Index

114

Concepts

All Affiliations

Justus-Liebig-Universität Gießen Kerckhoff Klinik

About

G. Müller‐Berghaus is an author at Justus-Liebig-Universität Gießen specializing in medicine, thrombosis, and hematology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	27	43	3.9K
2	Natural Sciences	11	11	727
3	Health Sciences	5	5	268
4	Engineering	2	2	62
5	Education	1	1	24

G. Müller‐Berghaus

Publications

5.4K

Citations

H-Index

Page 1

	Year	Citations
CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells Volker Henn, Joseph R. Slupsky, Michael Gräfe, Nature InflammationThrombosisThrombopoiesisEndothelial CellsBlood Platelet	1998	2.1K
Purification and characterization of a plasminogen activator inhibitor 1 binding protein from human plasma. Identification as a multimeric form of S protein (vitronectin). Paul Declerck, M De Mol, Marie‐Christine Alessi, Journal of Biological Chemistry	1988	486
Specific binding of the human S protein (vitronectin) to streptococci, Staphylococcus aureus, and Escherichia coli Gursharan S. Chhatwal, Klaus T. Preissner, G. Müller‐Berghaus, Infection and Immunity BacteriologyStaphylococcus AureusEscherichia ColiMedical MicrobiologySpecific Binding	1987	217
Monitoring of r-Hirudin Anticoagulation during Cardiopulmonary Bypass – Assessment of the Whole Blood Ecarin Clotting Time Bernd Pötzsch, Katharina Madlener, Christoph Seelig, Thrombosis and Haemostasis	1997	187
Physicochemical characterization of human S-protein and its function in the blood coagulation system Klaus T. Preissner, G. Müller‐Berghaus Biochemical Journal Protein PurificationPhysicochemical CharacterizationBioanalysisHematologyImmunochemistry	1985	183
Neutralization and binding of heparin by S protein/vitronectin in the inhibition of factor Xa by antithrombin III. Involvement of an inducible heparin-binding domain of S protein/vitronectin. Klaus T. Preissner, G. Müller‐Berghaus Journal of Biological Chemistry	1987	171
Structural requirements for the extracellular interaction of plasminogen activator inhibitor 1 with endothelial cell matrix-associated vitronectin. Klaus T. Preissner, J. Grulich‐Henn, Hartmut J. Ehrlich, Journal of Biological Chemistry	1990	118
MONITORING OF RECOMBINANT HIRUDIN: ASSESSMENT OF A PLASMA-BASED ECARIN CLOTTING TIME ASSAY Bernd Pötzsch, Simone Hund, Katharina Madlener, Thrombosis Research ThrombosisMedicineBioanalysisHematologyLaboratory Medicine	1997	114
Increased blood fibrinolytic activity after physical exercise: Comparative study in individuals with different sporting activities and in patients after myocardial infarction taking part in a rehabilitation sports program Wolfgang Speiser, Werner Langer, Andreas Pschaick, Thrombosis Research Sport RehabilitationPhysical ActivityKinesiologyExerciseMyocardial Infarction	1988	90
Recombinant hirudin as a new anticoagulant during cardiac operations instead of heparin: Successful for aortic valve replacement in man Friedrich‐Christian Rieß, C. Löwer, Christoph Seelig, Journal of Thoracic and Cardiovascular Surgery ThrombosisCardiovascular DiseaseHematologyRecombinant HirudinVascular Surgery	1995	88

Page 1